To evaluate the safety and efficiency of a novel blunt needle in reducing arterial injuries and bleeding complications during percutaneous nephrolithotomy (PCNL), emphasizing the importance of minimizing these risks.
Key Findings:
Conventional needles caused significant arterial injuries in 13.6 to 26.5% of cases, while the blunt needle design effectively reduced this incidence.
Blunt needles maintained similar puncture resistance to conventional needles, indicating comparable usability.
Interpretation:
The use of a blunt needle may significantly enhance the safety of renal access during PCNL by minimizing the risk of arterial injury and subsequent bleeding, with potential implications for broader clinical practice.
Limitations:
Study conducted in ex vivo conditions; results may vary in live patients, and potential biases in study design should be considered.
Blinding was not possible for surgeons due to the design differences of the needles.
Conclusion:
The blunt puncture concept presents a promising approach to improve safety in PCNL by reducing bleeding complications associated with conventional needle use, warranting further studies in live patients.
A hallmark of Fox Chase leadership, fellows, residents and faculty is their ability to persevere—to keep climbing the often-difficult ascent of cancer discovery and delivery—no matter what. Meet some of the exceptional researchers, scientists, and clinicians determined to make decisive inroads in cancer care.
